Skip to main content
a group of glass bottles on a table

Hikma launches Diazepam injection

Diazepam injection is indicated for the management of anxiety disorders as well as for symptoms of acute alcohol withdrawal.
Levy

Hikma is offering a Diazepam injection in a 50 mg/10 ml dose.

Diazepam injection is indicated for the management of anxiety disorders or the short-term relief of the symptoms of anxiety as well as symptoms of acute alcohol withdrawal.

It also is a useful adjunct in status epilepticus and may help relax muscles or relieve muscle spasms.

[Read more: Hikma to launch 4 generics in Canada]

Hikma also markets Diazepam in prefilled syringe form.

[Read more: Hikma to acquire Custopharm]

Diazepam injection had a market value of approximately $4 million in the 12 months ending February 2023, per IQVIA.

X
This ad will auto-close in 10 seconds